Important pharmacy news and late-breaking industry information updated daily.
Cost-cutting measures that have slowed mail delivery through the U.S. Postal Service (USPS) are being viewed as political maneuvering, but Americans of all stripes are hurting from delays in receiving mail-order prescriptions.
APhA, the National Association of Chain Drug Stores, and the National Community Pharmacists Association welcomed new federal efforts to give pharmacists more responsibility on childhood vaccinations.
The Justice Department has lodged a lawsuit against the U.S. unit of Teva Pharmaceuticals, which allegedly used $300 million in charitable donations to insulate Medicare patients from escalating drug costs.
Community pharmacists’ scope of practice is widening during COVID-19, with more patients seeking care from pharmacists and more pharmacies anticipating increased point-of-care testing and expanded immunization services.
As months of negotiations drag on, states are asking pharmaceutical giants to contribute an estimated $26.4 billion toward healing the hurt caused by America's opioid crisis. The new demand came Monday from about a dozen state attorneys general (AGs), who want $21.14 billion from McKesson Corp., Cardinal Health, and AmerisourceBergen Corp.
The American College of Cardiology (ACC) released updated guidance on using diabetes medications to reduce cardiovascular risk in patients who have type 2 diabetes.
The prospect of a resurgence in COVID-19 cases colliding with a severe influenza season is stoking fear of a "twindemic" that could prove disastrous for people infected with both respiratory viruses and challenging for an already strained health care system.
The approaching influenza season threatens to overwhelm hospitals swamped by COVID-19 patients, prompting increased efforts to get people vaccinated against influenza.
FDA has granted accelerated approval to viltolarsen (Viltepso—NS Pharma) injection for the treatment of Duchenne muscular dystrophy (DMD) in individuals with a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
U.S. lawmakers sent a letter to FDA calling on the agency to temporarily clear the market of all e-cigarettes for the duration of the COVID-19 pandemic. The letter cites emerging research that suggests vaping or using e-cigarettes can come with an increased risk of being diagnosed with COVID-19 and suffering symptoms.